INTELLECTUAL PROPERTY
Angeles Therapeutics has pursued a multi-layered intellectual property strategy to protect its various technology platforms and their application to the treatment of cancer and other diseases.
- Angeles owns or has an exclusive license to 16 patent families covering cell and immune therapies.
- Global IP protection (issued and pending patents) covering 60-70 countries/regions.
- >200 granted or pending patent applications worldwide
- Angeles has one of the largest portfolios of CARs in the world targeting >130 antigens